How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation Assumptions [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
NeuroPace is back on investor radar as analysts update their models and lift the fair value price target from US$19.43 to about US$19.88. Some see this roughly US$0.45 move as better aligned with revised expectations around the company's growth trajectory. Others point out that it may leave less room for error if forecasts do not play out as modeled. As you read on, you will see how these shifts shape the evolving narrative and what to watch next in the story. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value NeuroPace. What Wall Street Has Been Saying ?? Bullish Takeaways H.C. Wainwright raised its NeuroPace price target by US$1, which lines up with the recent lift in the broader fair value estimate to about US$19.88 and signals increased conviction around the company's potential. Wells Fargo assumed coverage of NeuroPace with an Overweight rating, indicating that, in its view, the risk and reward tradeoff
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace (NPCE) was upgraded by Wells Fargo & Company to "strong-buy".MarketBeat
- NeuroPace (NPCE) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NPCE&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" to "holMarketBeat
- NeuroPace (NPCE) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NPCE&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "buy"MarketBeat
- NeuroPace to Present at the Leerink Global Healthcare ConferenceBusiness Wire
- NeuroPace (NPCE) was upgraded by Cantor Fitzgerald to "strong-buy".MarketBeat
NPCE
Earnings
- 3/3/26 - Beat
NPCE
Sec Filings
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- 3/23/26 - Form 4
- NPCE's page on the SEC website